Articles with "metyrapone" as a keyword



Photo by elisa_ventur from unsplash

Metyrapone abolishes Spike-Wave Discharge seizures in GAERS by reducing stress hormones.

Sign Up to like & get
recommendations!
Published in 2023 at "Epilepsia"

DOI: 10.1111/epi.17584

Abstract: OBJECTIVE Stress is one of the most commonly reported triggers for seizures in patients with epilepsy, although the mechanisms which mediate this effect are not established. The clinical evidence supporting this is derived from patient's… read more here.

Keywords: stress; spike wave; stress hormones; seizures gaers ... See more keywords
Photo from wikipedia

Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of the Endocrine Society"

DOI: 10.1210/jendso/bvaa167

Abstract: Abstract Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushing… read more here.

Keywords: cortisol; metyrapone; pregnancy; adrenal cushing ... See more keywords
Photo from wikipedia

Maternal Metyrapone Use During Breastfeeding: Safe for the Breastfed Infant

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of the Endocrine Society"

DOI: 10.1210/js.2018-00355

Abstract: Abstract Context Metyrapone is an inhibitor of endogenous adrenal corticosteroid synthesis, which has been proven to be a viable option in controlling maternal serum cortisol concentrations during pregnancy. The infant exposure to maternally ingested metyrapone… read more here.

Keywords: metyrapone; metyrapone use; breast milk; maternal metyrapone ... See more keywords
Photo from wikipedia

Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-Dependent Cushing Syndrome Patients.

Sign Up to like & get
recommendations!
Published in 2022 at "European journal of endocrinology"

DOI: 10.1530/eje-22-0208

Abstract: INTRODUCTION Osilodrostat is a new 11 ß-hydroxylase inhibitor with a mode of action analogue to Metyrapone. The objective of this study was to compare steroidogenic profiles in patients treated by either Osilodrostat or Metyrapone for… read more here.

Keywords: endocrinology; patients treated; osilodrostat metyrapone; acth dependent ... See more keywords